MARYSVILLE, Ohio, Oct. 11, 2016 -- The Scotts Miracle-Gro Company (NYSE:SMG), the world’s largest marketer of branded consumer lawn and garden products, will release its fourth quarter financial results on Thursday, November 3, 2016, prior to the opening of the U.S. financial markets. The Company will host a conference call to discuss those results at 9:00 a.m. ET.
To participate in the conference call, please call 888-394-8206 (Conference Code: 1007538). A replay of the call can be heard by calling 888-203-1112. The replay will be available for 30 days.
A live webcast of the call and the press release will be available on the investor relations section of the Company’s corporate website at http://investor.scotts.com. An archive of the press release and any accompanying information will remain available for at least a 12-month period.
About ScottsMiracle-Gro
With approximately $3 billion in worldwide sales, The Scotts Miracle-Gro Company is the world's largest marketer of branded consumer products for lawn and garden care. The Company's brands are the most recognized in the industry. In the U.S., the Company's Scotts®, Miracle-Gro® and Ortho® brands are market-leading in their categories, as is the consumer Roundup® brand, which is exclusively marketed near worldwide by Scotts and owned by Monsanto. In Europe, the Company's brands include Weedol®, Pathclear®, Evergreen®, Levington®, Miracle-Gro®, KB®, Fertiligène® and Substral®. In 2016, the Company ranked on Forbes 100 Most Reputable Companies in America. For additional information, visit us at www.scottsmiraclegro.com.
Contact: Jim King Senior Vice President Chief Communications Officer 937-578-5622


Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Italy Fines Apple €98.6 Million Over App Store Dominance
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 



